These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26378516)

  • 1. Design, Synthesis and Biological Evaluation of Novel Substituted N,N'-Diaryl ureas as Potent p38 Inhibitors.
    Zhu D; Li X; Zhong W; Zhao D
    Molecules; 2015 Sep; 20(9):16604-19. PubMed ID: 26378516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and characterization of N', N"-diaryl ureas as p38 kinase inhibitors.
    Kulkarni RG; Laufer S; Mangannavar C; Garlapati A
    Med Chem; 2013 Mar; 9(2):213-21. PubMed ID: 22946566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors.
    Heo J; Shin H; Lee J; Kim T; Inn KS; Kim NJ
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3694-8. PubMed ID: 26115577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38α.
    Getlik M; Grütter C; Simard JR; Nguyen HD; Robubi A; Aust B; van Otterlo WA; Rauh D
    Eur J Med Chem; 2012 Feb; 48():1-15. PubMed ID: 22154891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors.
    Sabatini S; Manfroni G; Barreca ML; Bauer SM; Gargaro M; Cannalire R; Astolfi A; Brea J; Vacca C; Pirro M; Massari S; Tabarrini O; Loza MI; Fallarino F; Laufer SA; Cecchetti V
    Chem Biol Drug Des; 2015 Oct; 86(4):531-45. PubMed ID: 25589097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds.
    Murali Dhar TG; Wrobleski ST; Lin S; Furch JA; Nirschl DS; Fan Y; Todderud G; Pitt S; Doweyko AM; Sack JS; Mathur A; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5019-24. PubMed ID: 17664068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region.
    Laufer SA; Hauser DR; Domeyer DM; Kinkel K; Liedtke AJ
    J Med Chem; 2008 Jul; 51(14):4122-49. PubMed ID: 18578517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and p38 Inhibitory Activity of Some Novel Substituted N,N'-Diarylurea Derivatives.
    Zhu D; Xing Q; Cao R; Zhao D; Zhong W
    Molecules; 2016 May; 21(5):. PubMed ID: 27223276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Biological Evaluation of 2,3,4-Triaryl-1,2,4-oxadiazol-5-ones as p38 MAPK Inhibitors.
    Romeo R; Giofrè SV; Chiacchio MA; Veltri L; Celesti C; Iannazzo D
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33804659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.
    Kim DK; Lim JH; Lee JA; Dewang PM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
    Xing L; Shieh HS; Selness SR; Devraj RV; Walker JK; Devadas B; Hope HR; Compton RP; Schindler JF; Hirsch JL; Benson AG; Kurumbail RG; Stegeman RA; Williams JM; Broadus RM; Walden Z; Monahan JB
    Biochemistry; 2009 Jul; 48(27):6402-11. PubMed ID: 19496616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1.
    Kaieda A; Takahashi M; Fukuda H; Okamoto R; Morimoto S; Gotoh M; Miyazaki T; Hori Y; Unno S; Kawamoto T; Tanaka T; Itono S; Takagi T; Sugimoto H; Okada K; Snell G; Bertsch R; Nguyen J; Sang BC; Miwatashi S
    ChemMedChem; 2019 May; 14(10):1022-1030. PubMed ID: 30945818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azastilbenes: a cut-off to p38 MAPK inhibitors.
    Poon JF; Alao JP; Sunnerhagen P; Dinér P
    Org Biomol Chem; 2013 Jul; 11(27):4526-36. PubMed ID: 23719673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Displacement assay for the detection of stabilizers of inactive kinase conformations.
    Klüter S; Grütter C; Naqvi T; Rabiller M; Simard JR; Pawar V; Getlik M; Rauh D
    J Med Chem; 2010 Jan; 53(1):357-67. PubMed ID: 19928858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tri- and tetrasubstituted imidazoles as p38α mitogen-activated protein kinase inhibitors.
    Laufer S; Hauser D; Stegmiller T; Bracht C; Ruff K; Schattel V; Albrecht W; Koch P
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6671-5. PubMed ID: 20934337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amide-based inhibitors of p38alpha MAP kinase. Part 1: discovery of novel N-pyridyl amide lead molecules.
    Luedtke GR; Schinzel K; Tan X; Tester RW; Nashashibi I; Xu YJ; Dugar S; Levy DE; Jung J
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2556-9. PubMed ID: 20346653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase.
    Walker JK; Selness SR; Devraj RV; Hepperle ME; Naing W; Shieh H; Kurambail R; Yang S; Flynn DL; Benson AG; Messing DM; Dice T; Kim T; Lindmark RJ; Monahan JB; Portanova J
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2634-8. PubMed ID: 20227876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an allosteric and Smad3-selective inhibitor of p38αMAPK using a substrate-based approach.
    Nagao H; Kitagawa D; Nakajima F; Sawa M; Kinoshita T
    Bioorg Med Chem Lett; 2021 Jul; 43():128056. PubMed ID: 33892104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors.
    Park H; Lee S; Hong S
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3784-7. PubMed ID: 26259807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and structure-activity relationships for some triazolyl p38α MAPK inhibitors.
    Seerden JP; Leusink-Ionescu G; Leguijt R; Saccavini C; Gelens E; Dros B; Woudenberg-Vrenken T; Molema G; Kamps JA; Kellogg RM
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1352-7. PubMed ID: 24508134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.